iShares J.P. Morgan EM High Yield Bond ETF (EMHY) is an exchange-traded fund that seeks to track the investment results of the J.P. Morgan USD Emerging Markets High Yield Bond Index, composed of U.S. dollar-denominated high yield sovereign and corporate bonds issued by emerging market entities. The fund provides exposure to below investment-grade fixed and floating-rate debt securities from issuers headquartered in emerging markets or with operations predominantly in regions such as Africa, Asia (excluding Japan), Eastern Europe, the Middle East, and Latin America; eligible bonds include corporate instruments with at least USD 500 million face amount outstanding and sovereign/quasi-sovereign debt with USD 1 billion or more, all featuring minimum remaining maturities of 2.5 years. Top holdings typically feature bonds from issuers like Turkey (Republic of), Argentina Republic of Government, Brazil Federative Republic of Government, Petroleos Mexicanos, and Colombia (Republic of), alongside others such as Dominican Republic Government, Egypt, South Africa, Nigeria, and Ecopetrol SA.
Launched on April 3, 2012 and managed by BlackRock under its iShares brand, EMHY operates with a 0.50% expense ratio and is listed on U.S. exchanges with headquarters aligned to BlackRock's operations in Wilmington, Delaware. The ETF targets institutional and retail investors seeking high yield income from emerging markets fixed income, with geographic focus spanning sovereigns and corporates across Latin America, Europe (emerging), Middle East, Africa, and Asia.
In recent developments as of late 2025, EMHY has maintained stable operations amid broader BlackRock iShares expansions, including rebranding initiatives and new active ETF launches, though no specific acquisitions, partnerships, or index reconstitutions directly impact the fund. Performance highlights include a 12.65% total return in 2024 and year-to-date gains reflecting renewed interest in emerging markets high yield amid policy easing and attractive valuations; monthly distributions continue, with recent payouts underscoring its income focus. The fund remains non-ESG oriented, prioritizing benchmark replication over sustainable strategies.